Korean K-beauty skincare brand known for white-truffle serums/ampoules, sold direct-to-consumer and exported, notably to Japan.
Korean K-beauty skincare brand known for white-truffle serums/ampoules, sold direct-to-consumer and exported, notably to Japan.
Moat: narrow (brand). Fast-growing niche K-beauty brand riding social-media-driven demand, though trend-dependent.
Headquarters: South Korea · Employees: 203
Size d'Alba Global (483650.KS) is a South Korea Consumer Staples company (Household/Personal Care) with a market value of $1.13B, the 219th largest of 483 South Korea companies the cockpit tracks. Shares closed at ₩116,500 on 18 Nov 2026.
Performance Over six months the shares fell 55.2%, against +10.5% for the median peer and -37.2% for the South Korea market (cap-weighted) — lowest of 21 in its peer set.
Growth Revenue grew 48.9% over the last twelve months (peer median +8.8%); the operating margin is 22.3% (peer median 8.9%).
Valuation It trades at 12.0× forward earnings against a peer median of 19.8× (3rd cheapest of 21).
Price implies For today's price to make sense, revenue must grow about -7% a year for seven years (Req g). Recent delivered growth is +53%, so the hurdle is -60 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 121.0 points above its cost of capital (7.6% WACC).
Next results Next results expected around 19 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₩677B | ₩520B | ₩309B | ₩201B | ₩145B |
| Revenue growth | — | +68% | +54% | +38% | — |
| Gross profit | ₩515B | ₩393B | ₩234B | ₩146B | n/a |
| EBITDA | ₩153B | ₩103B | ₩60.6B | ₩32.9B | n/a |
| Net income | ₩110B | ₩79.1B | ₩15.4B | ₩13.6B | ₩891M |
| Free cash flow | ₩114B | ₩68.2B | ₩15.0B | ₩24.2B | n/a |
| Capital expenditure | ₩1.54B | ₩380M | ₩1.14B | ₩79.0M | n/a |
| Total debt | ₩4.03B | ₩2.94B | ₩2.82B | ₩6.38B | ₩1.28B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 483650.KS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -28.4% | -0.5% | 2nd lowest of 21 |
| 6-month return | -55.2% | +10.5% | lowest of 21 |
| Distance from 52-week high | -58.8% | -27.4% | 2nd lowest of 21 |
| Revenue growth (TTM) | +48.9% | +8.8% | 2nd highest of 21 |
| Operating margin | 22.3% | 8.9% | 2nd highest of 21 |
| Forward P/E | 12.0× | 19.8× | 3rd cheapest of 21 |
| Growth the price implies (Req g, 7 yrs) | -6.6% | 4.3% | 2nd least demanding of 18 |
| Growth delivered (Del g) | +53.0% | +8.9% | highest of 18 |
| Hurdle (Req g minus delivered) | -59.6 pp | -4.4 pp | least demanding of 18 |
| ROIC minus cost of capital | +121.0 pp | +7.1 pp | highest of 21 |
| EV / EBITDA | 8.7× | 10.4× | 3rd cheapest of 12 |
| Net debt / EBITDA | -1.2× | -1.1× | 6th least indebted of 12 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| d'Alba Global 483650.KS | South Korea | $1.13B | -55% | +49% | 22% | 12.0× | -6.6% | +53.0% |
| Shanghai Chicmax Cosmetics 2145.HK | Hong Kong | $1.17B | -42% | +23% | 8% | 14.4× | -6.1% | +21.2% |
| Shanghai Forest Cabin Cosmetics 2657.HK | Hong Kong | $1.04B | +15% | +74% | 18% | 11.8× | 11.3% | +49.0% |
| Edgewell Personal Care EPC | United States | $1.30B | +67% | -10% | 7% | 14.2× | n/a | n/a |
| Noevir 4928.T | Japan | $978M | +7% | -3% | 28% | 20.4× | -12.8% | +4.1% |
| Chongqing Baiya Sanitary Products 003006.SZ | China | $1.35B | +27% | 0% | 3% | 37.3× | 28.8% | +22.8% |
| Tongling Jieya Biologic Technology 301108.SZ | China | $933M | +56% | +24% | 5% | 52.5× | 28.5% | +0.8% |
| Runben Biotechnology 603193.SS | China | $918M | -30% | +13% | 21% | 18.5× | 1.5% | +28.4% |
| Dencare (Chongqing) Oral Care 001328.SZ | China | $912M | +13% | +10% | 11% | 27.9× | 3.7% | +10.8% |
| Intercos ICOS.MI | Italy | $1.43B | +12% | -5% | 9% | 18.9× | 4.3% | +11.5% |
| Harbin Fuerjia Technology 301371.SZ | China | $1.51B | -39% | +28% | 20% | 21.4× | 7.5% | +3.6% |
| Cosmecca Korea 241710.KS | South Korea | $847M | +23% | +42% | 12% | 16.3× | n/a | n/a |
| Galaxy Surfactants GALAXYSURF.NS | India | $845M | +22% | +30% | 9% | 17.6× | 18.5% | +13.7% |
| SYoung 300740.SZ | China | $816M | -48% | +14% | 3% | 33.4× | 14.0% | +6.1% |
| AMOREPACIFIC 002790.KS | South Korea | $1.61B | +2% | +9% | 9% | 8.5× | -5.7% | -1.3% |
| Shanghai Jahwa United 600315.SS | China | $1.61B | -15% | +9% | 2% | 15.4× | 15.3% | -2.1% |
| Guangdong Marubi Biotechnology 603983.SS | China | $1.62B | +9% | -6% | 2% | 45.5× | n/a | n/a |
| Jyothy Labs JYOTHYLAB.NS | India | $762M | -9% | +5% | 8% | 40.8× | 34.5% | +8.9% |
| Yunnan Botanee Bio-Technology 300957.SZ | China | $1.69B | -33% | +7% | 9% | 19.1× | 2.6% | +15.3% |
| Milbon 4919.T | Japan | $743M | +48% | +8% | 14% | 25.7× | -3.3% | +8.2% |
| Pigeon 7956.T | Japan | $1.76B | +26% | +8% | 13% | 27.9× | -2.4% | +1.9% |